1
0
KHARTOUM, Sudan, September 18, 2022/APO Group/ –Sudan’s outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) has been successfully stopped, according to experts from WHO, UNICEF and the United States Centers for Disease Control and Prevention.
Declared in 15 out of 18 states, the outbreak was caused by a circulating vaccine-derived poliovirus (cVDPV2) strain imported from Chad, paralyzing 58 children.
Today’s announcement comes after virtual and in-country reviews of Sudan’s response to the outbreak and its surveillance system by a team of experts in polio eradication, global public health, epidemiology, and vaccine management. The final Outbreak Response Assessment, held between 24 July and 1 August 2022, included interviews and reviews of reports and records with surveillance and immunization staff at state, locality, and health facility levels. The findings of the Outbreak Response Assessment, coupled with the absence of the cVDPV2 virus for more than 18 months in the presence of sustained high-quality poliovirus surveillance, make it possible to conclude that the cVDPV2 outbreak can now be declared closed.
Two nationwide campaigns using mOPV2 covered all 18 states in November 2020 and January 2021, reaching over 8 million children under 5 in each of the 2 rounds
“The Federal Ministry of Health declared the cVDPV2 outbreak during a difficult time of multiple emergencies, starting with the COVID-19 pandemic lockdown. Economic downturn and political instability were additional challenges during the start of the outbreak. The Federal Ministry of Health worked with partners and implemented a robust outbreak response plan that included 2 rounds of high-quality campaigning. Sudan is an example of how an early, rapid and coordinated response can stop an outbreak,” said Dr Haitham Muhammad Ibrahim Awad Allah, Federal Minister of Health.
“The closure of this outbreak speaks to the skill and diligence of health workers and public health officials in Sudan, and to the extraordinary commitment of the Government of Sudan demonstrated by allocation of significant domestic financial resources to the response, during one of the most challenging periods of the COVID-19 pandemic,” said Dr Ahmed Al-Mandhari, WHO Regional Director for the Eastern Mediterranean.
Backed by UNICEF and WHO, the Federal Ministry of Health successfully organized 2 nationwide vaccination campaigns targeting children under-5 years of age to contain the spread of poliovirus, reaching over 95% of the target population. Community engagement and social mobilization efforts were stepped up to ensure information about the dangers of the disease and the need to immunize every eligible child reached every household.
“Two nationwide campaigns using monovalent oral polio vaccine type 2 (mOPV2) covered all 18 states in November 2020 and January 2021, reaching over 8 million children under 5 in each of the 2 rounds. In every location, vaccinators took precautions against COVID-19, including using hand sanitizer and wearing masks. Despite the closure of the outbreak, the country remains vigilant for possible poliovirus importation,” said Dr Nima Saeed Abid, WHO Representative in Sudan.
“The closure of the polio outbreak is a remarkable achievement for the children of Sudan. Community engagement has been at the heart of efforts to turn vaccines into vaccinations for over 8 million children. This success is a testament to the commitment of health workers, especially women, who continue to work selflessly and passionately to deliver vaccines. As we celebrate this achievement and the strong partnerships that made it possible, we must remain alert to protect Sudan from future outbreaks; there is no room for complacency,” said Mandeep O’Brien, UNICEF Representative in Sudan. “In addition to sensitive surveillance, improved coverage of routine vaccinations is important to protect children from poliomyelitis and other vaccine-preventable diseases,” she continued.
Across the Eastern Mediterranean Region, cVDPV2 cases have increased in recent years, and the movement of people across borders underscores the risk of importation across and beyond the Region. The cVDPV2 strain that led to 58 cases in Sudan has been detected in 8 neighboring countries before and after Sudan’s outbreak. While the international spread is a reminder that polio anywhere is a risk to children everywhere, the closure of Sudan’s outbreak shows what can be achieved with strong national commitment and high-quality vaccination campaigns, on-the-ground leadership, sensitive surveillance measures, and essential immunizations.
Distributed by APO Group on behalf of World Health Organization Regional Office for the Eastern Mediterranean.
About Author
OTHER ARTICLES
Zambia : The vital role of community health assistants in public health surveillance
Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.
Confirmed Case of Mpox in Senegal: Situation Update (as of August 27, 2025)